Mechanisms and disease consequences of nonalcoholic fatty liver disease

R Loomba, SL Friedman, GI Shulman - Cell, 2021 - cell.com
Nonalcoholic fatty liver disease (NAFLD) is the leading chronic liver disease worldwide. Its
more advanced subtype, nonalcoholic steatohepatitis (NASH), connotes progressive liver …

Arachidonic acid metabolism and kidney inflammation

T Wang, X Fu, Q Chen, JK Patra, D Wang… - International journal of …, 2019 - mdpi.com
As a major component of cell membrane lipids, Arachidonic acid (AA), being a major
component of the cell membrane lipid content, is mainly metabolized by three kinds of …

Lipid accumulation and chronic kidney disease

Z Gai, T Wang, M Visentin, GA Kullak-Ublick, X Fu… - Nutrients, 2019 - mdpi.com
Obesity and hyperlipidemia are the most prevalent independent risk factors of chronic
kidney disease (CKD), suggesting that lipid accumulation in the renal parenchyma is …

An overview of lipid metabolism and nonalcoholic fatty liver disease

K Pei, T Gui, D Kan, H Feng, Y **… - BioMed Research …, 2020 - Wiley Online Library
The occurrence of nonalcoholic fatty liver disease (NAFLD) is associated with major
abnormalities of hepatic lipid metabolism. We propose that lipid abnormalities directly or …

The polysaccharides from Auricularia auricula alleviate non-alcoholic fatty liver disease via modulating gut microbiota and bile acids metabolism

Y Shu, Y Huang, W Dong, X Fan, Y Sun, G Chen… - International Journal of …, 2023 - Elsevier
The polysaccharides from Auricularia auricula (AAPs), containing a large number of O-acetyl
groups that are related to the physiological and biological properties, seem to be potential …

Bile acids and their receptors: modulators and therapeutic targets in liver inflammation

A Bertolini, R Fiorotto, M Strazzabosco - Seminars in immunopathology, 2022 - Springer
Bile acids participate in the intestinal emulsion, digestion, and absorption of lipids and fat-
soluble vitamins. When present in high concentrations, as in cholestatic liver diseases, bile …

Update on FXR biology: promising therapeutic target?

CY Han - International journal of molecular sciences, 2018 - mdpi.com
Farnesoid X receptor (FXR), a metabolic nuclear receptor, plays critical roles in the
maintenance of systemic energy homeostasis and the integrity of many organs, including …

Nonalcoholic fatty liver disease and chronic kidney disease: epidemiology, pathogenesis, and clinical and research implications

A Lonardo, A Mantovani, G Targher, G Baffy - International Journal of …, 2022 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD) has become the most common cause of chronic
liver disease worldwide, affecting up to~ 30% of adult populations. NAFLD defines a …

Bile acid and receptors: Biology and drug discovery for nonalcoholic fatty liver disease

T Jiao, Y Ma, X Guo, Y Ye, C **e - Acta Pharmacologica Sinica, 2022 - nature.com
Nonalcoholic fatty liver disease (NAFLD), a series of liver metabolic disorders manifested by
lipid accumulation within hepatocytes, has become the primary cause of chronic liver …

Geniposide ameliorates liver fibrosis through reducing oxidative stress and inflammatory respose, inhibiting apoptosis and modulating overall metabolism

L Yang, L Bi, L **, Y Wang, Y Li, Z Li, W He… - Frontiers in …, 2021 - frontiersin.org
Liver fibrosis is a progressive liver damage condition caused by various factors and may
progress toward liver cirrhosis, and even hepatocellular carcinoma. Many studies have …